Economic Atlas
Companies/TuHURA Biosciences, Inc.
Company profile

TuHURA Biosciences, Inc.

NASDAQ: HURA · Healthcare · Biotechnology
PublicHQ Tampa, CIK 0001498382Reports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
36D
Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$30.1M
Employees
22
as of 2026-08-14
Market cap
$146.5M
as of 2026-08-14

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$0$02025
Net income-$30.1M-$30.1M2025
Operating income-$57.6k-$57.6k2012
Total assets$27.4M$27.4M2025
Liabilities$6.4M$6.4M2025
Equity$20.9M$20.9M2025

Revenue trend

FY2012 – FY2025 · USD
FY12
FY12
FY24
FY24
FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is TuHURA Biosciences, Inc.’s revenue?

TuHURA Biosciences, Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare
Immuneering Corporation43DNkarta, Inc.47DOnKure Therapeutics, Inc.46DSpruce Biosciences, Inc.40DAardvark Therapeutics, Inc. Common Stock40DHelix BioPharma Corp.——
Key facts
CEOJames A. Bianco
SectorHealthcare
IndustryBiotechnology
HeadquartersTampa, null
ExchangeNASDAQ: HURA
Employees22
IPO date2013-02-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.